130
Participants
Start Date
June 30, 2025
Primary Completion Date
January 31, 2026
Study Completion Date
July 31, 2026
GV101
GV101 suspension
GV101 placebo
GV101 placebo suspension
Coastal Research Institute, LLC, Fayetteville
Lakeview Clinical Research, LLC, Guntersville
Louisville Metabolic and Atherosclerosis Research Center (L-MARC), Louisville
Velocity Clinical Research - Cleveland, Cleveland
Lillestol Research, LLC, Fargo
Mercury Street Medical, Butte
Study Metrix Research, City of Saint Peters
Kansas City Research Institute, Kansas City
Tandem Clinical Research, Marrero
Velocity Clinical Research - Dallas, Dallas
Advanced Research Institute - Ogden, Ogden
Chrysalis Clinical Research, St. George
Arizona Clinical Trials, Tucson
Catalina Research Institute, LLC, Montclair
Encompass Clinical Research, Spring Valley
Hassman Research Institute, Berlin
Hadassah Medical Center Ein Karem, Jerusalem
Hasharon Hospital, Petah Tikva
Rabin Medical Center, Beilinson Hospital, Petah Tikva
Sheba Medical Center, Tel Litwinsky
Lead Sponsor
Graviton Bioscience Corporation
INDUSTRY